TAC
Showing 1 - 25 of 612
Metastatic Solid Tumor Trial (TAC01-CLDN18.2)
Not yet recruiting
- Metastatic Solid Tumor
- TAC01-CLDN18.2
- (no location specified)
May 8, 2023
Adolescent Behavior, Physical Activity, New Technologies Trial ("PACER" Application, "MapMyWalk" Application, "Strava"
Not yet recruiting
- Adolescent Behavior
- +2 more
- "PACER" Application
- +6 more
- (no location specified)
Nov 14, 2023
Hyperspectral Imaging Technique in the Treatment of IMN by TAC
Not yet recruiting
- Idiopathic Membranous Nephropathy
- +2 more
- Tacrolimus for the treatment of IMN
- (no location specified)
Mar 31, 2023
Advanced Hepatocellular Carcinoma Trial in Chengdu (Lenvatinib combined with TACE and Camrelizumab)
Recruiting
- Advanced Hepatocellular Carcinoma
- Lenvatinib combined with TACE and Camrelizumab
-
Chengdu, Sichuan, ChinaHuaXi hospital
Feb 12, 2023
Tacrolimus Blood Concentration and Transplant-related Outcomes
Recruiting
- Graft Vs Host Disease
- +2 more
- TAC C/D ratio
-
Trieste, ItalyIRCCS Burlo Garofolo
Oct 6, 2023
Prognostic Model of TAC in the Treatment of MN
Not yet recruiting
- Idiopathic Membranous Nephropathy
- (no location specified)
Dec 28, 2022
Lymphoma, B-Cell Trial (TAC01-CD19)
Withdrawn
- Lymphoma, B-Cell
- TAC01-CD19
- (no location specified)
Feb 7, 2022
HER2-Positive Solid Tumors Trial in Canada, United States (TAC01-HER2)
Recruiting
- HER2-Positive Solid Tumors
- TAC01-HER2
-
Chicago, Illinois
- +4 more
Apr 27, 2022
Idiopathic Membranous Nephropathy Trial (glucocorticoid + tacrolimus)
Not yet recruiting
- Idiopathic Membranous Nephropathy
- glucocorticoid + tacrolimus
- (no location specified)
Dec 28, 2022
Hepatocellular Carcinoma Trial in Pavia (TAC-101, Placebo)
Terminated
- Hepatocellular Carcinoma
- TAC-101
- Placebo
-
Pavia, ItalyI.R.C.C.S. San Matteo University Hospital, Golgi
Jan 3, 2022
Systemic Lupus Erythematosus, Lupus Nephritis Trial (Mycophenolate Mofetil, Tacrolimus, Glucocorticoid)
Not yet recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- Mycophenolate Mofetil
- +2 more
- (no location specified)
Jun 21, 2023
Dietary PI and TAC on Outcome of Pregnancy in In Vitro
Enrolling by invitation
- Ongoing Pregnancy
- In-vitro Fertilization
-
Ankara, Altındag, TurkeyHacettepe
May 26, 2023
Triple Negative Breast Cancer Trial in Zhengzhou (Docetaxel +doxorubicin+ cyclophosphamide, Docetaxel +Cisplatin)
Recruiting
- Triple Negative Breast Cancer
- Docetaxel +doxorubicin+ cyclophosphamide
- Docetaxel +Cisplatin
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 18, 2022
Hairy Cell Leukemia Trial run by the NCI (Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin)
Active, not recruiting
- Hairy Cell Leukemia
- Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 13, 2022
Liver Transplantation Trial in Stockholm (TCD601, Cyclophosphamide, TAC)
Recruiting
- Liver Transplantation
- TCD601
- +4 more
-
Stockholm, Huddinge, SwedenKarolinska University Hospital
Aug 25, 2023
Advanced Cancer Trial in New York (Talking about Cancer (TAC))
Completed
- Advanced Cancer
- Talking about Cancer (TAC)
-
New York, New YorkWeill Cornell Medicine
Jan 27, 2023
Kidney Transplant; Complications, Immune Suppression Trial in Oslo (Mycophenolate Mofetil 500 mg Tab, Tacrolimus capsule)
Active, not recruiting
- Kidney Transplant; Complications
- Immune Suppression
- Mycophenolate Mofetil 500 mg Tab
- Tacrolimus capsule
-
Oslo, NorwayOslo University Hospital
Apr 19, 2022
Renal Transplantation Trial (TCD601, belatacept, ATG)
Not yet recruiting
- Renal Transplantation
- TCD601
- +5 more
- (no location specified)
Dec 20, 2022
Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500
Recruiting
- Prevention of Chemotherapy-induced Myelosuppression
- ALRN-6924
- TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
-
Tamarac, Florida
- +14 more
Jan 31, 2023
Leptin, Adiponectin, FRAP and Tac in Early Childhood Caries
Recruiting
- Early Childhood Caries
- Salivary sample analysis
-
Novi Sad, Vojvodina, SerbiaFaculty of Medicine, University of Novi Sad
Apr 24, 2022
Keloid, Keloid Scar Following Surgery Trial in Baton Rouge (Triamcinolone Injection, Triamcinolone Injection and 5-fluorouracil
Recruiting
- Keloid
- Keloid Scar Following Surgery
- Triamcinolone Injection
- Triamcinolone Injection and 5-fluorouracil injection
-
Baton Rouge, LouisianaOur Lady of the Lake Hospital
Sep 8, 2021
Systemic Lupus Erythematosus Trial (Telitacicept, Hydroxychloroquine, Prednisone)
Not yet recruiting
- Systemic Lupus Erythematosus
- Telitacicept
- +6 more
- (no location specified)
Dec 28, 2022
Immune Thrombocytopenia Trial in Beijing (TAC, Danazol)
Recruiting
- Immune Thrombocytopenia
- TAC
- Danazol
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jul 20, 2022
Liver Transplantation, Immunosuppression, Neurotoxicity Trial (Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release
Not yet recruiting
- Liver Transplantation
- +4 more
- Tacrolimus, Immediate Release, Oral
- Tacrolimus Extended Release Oral Tablet
- (no location specified)
Oct 20, 2021